| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | -49.9% |
| Cost of Revenue | $396K | -22.0% |
| Gross Profit | $803K | -57.4% |
| R&D Expense | $12.0M | +48.0% |
| SG&A Expense | $12.0M | +17.3% |
| Operating Income | -$23.3M | -40.9% |
| Income Tax | $0 | — |
| Net Income | -$22.7M | -42.1% |
| EPS (Basic) | -$1.29 | +50.8% |
| EPS (Diluted) | -$1.29 | +50.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.7M | -75.8% |
| Accounts Receivable | $104K | +23.8% |
| Current Assets | $5.5M | -72.2% |
| Total Assets | $10.3M | -59.9% |
| Current Liabilities | $4.1M | +58.3% |
| Total Liabilities | $4.6M | +24.9% |
| Stockholders' Equity | $5.7M | -74.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.6M | -34.4% |
| Capital Expenditures | $245K | -62.6% |
| Investing Cash Flow | -$595K | +7.0% |
| Financing Cash Flow | $4.7M | -83.8% |
| Free Cash Flow | -$18.9M | -30.1% |